Related Experiment Video
Updated: Jul 1, 2025
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Diagnostic Imaging for Retinoblastoma Cancer Staging: Guide for Providing Essential Insights for Ophthalmologists and
Vivek Pai1, Prakash Muthusami1, Birgit Ertl-Wagner1
1From the Divisions of Neuroradiology (V.P., P.M., B.E.W., M.M.S., C.P.F.) and Image Guided Therapy (P.M., M.M.S., C.P.F.), Department of Diagnostic Imaging, and Retinoblastoma Program, Department of Ophthalmology and Vision Sciences (K.S., S.K., A.M.), The Hospital for Sick Children (SickKids), University of Toronto, 555 University Ave, Toronto, ON, Canada M5G 1X8; and Department of Pathology and Department of Laboratory Medicine and Pediatrics, Cumming School of Medicine, Calgary, Alberta, Canada (M.A.B.).
Abstract:
Retinoblastoma is the most common cause of all intraocular pediatric malignancies. It is caused by the loss of RB1 tumor suppressor gene function, although some tumors occur due to MYCN oncogene amplification with normal RB1 genes. Nearly half of all retinoblastomas occur due to a hereditary germline RB1 pathogenic variant, most of which manifest with bilateral tumors. This germline RB1 mutation also predisposes to intracranial midline embryonal tumors. Accurate staging of retinoblastoma is crucial in providing optimal vision-, eye-, and life-saving treatment. The AJCC Cancer Staging Manual has undergone significant changes, resulting in a universally accepted system with a multidisciplinary approach for managing retinoblastoma. The authors discuss the role of MRI and other diagnostic imaging techniques in the pretreatment assessment and staging of retinoblastoma. A thorough overview of the prevailing imaging standards and evidence-based perspectives on the benefits and drawbacks of these techniques is provided. Published under a CC BY 4.0 license. Test Your Knowledge questions for this article are available in the supplemental material.
Insights
Retinoblastoma, a pediatric eye cancer, arises from RB1 gene mutations. Accurate staging using advanced imaging is vital for effective, life-saving treatment and preserving vision.
Area of Science:
- Ophthalmology
- Pediatric Oncology
- Genetics
- Radiology
Background:
- Retinoblastoma is the most frequent intraocular malignancy in children.
- It stems from RB1 tumor suppressor gene loss or MYCN oncogene amplification.
- Hereditary germline RB1 mutations predispose to bilateral tumors and intracranial embryonal tumors.
Purpose of the Study:
- To emphasize the critical role of accurate retinoblastoma staging for optimal treatment outcomes.
- To review the evolving AJCC Cancer Staging Manual's impact on retinoblastoma management.
- To discuss the utility of MRI and other imaging modalities in pretreatment assessment and staging.
Main Methods:
- Review of current diagnostic imaging techniques for retinoblastoma.
- Analysis of MRI's role in pretreatment assessment and staging.
- Evidence-based evaluation of the benefits and drawbacks of various imaging modalities.
Main Results:
- Accurate staging is paramount for vision-, eye-, and life-saving interventions.
- The AJCC Cancer Staging Manual provides a universally accepted, multidisciplinary approach.
- Diagnostic imaging, particularly MRI, is essential for pretreatment assessment and staging.
Conclusions:
- Multidisciplinary management and accurate staging are crucial for retinoblastoma.
- Advanced imaging techniques play a pivotal role in the pretreatment evaluation of retinoblastoma.
- Understanding the benefits and limitations of imaging modalities optimizes patient care.
